2018/19 FLU Campaign
Flu vaccination provides the best protection against an unpredictable virus which infects many people and can cause serious illness and death each year.
Flu is a highly infectious, acute, viral infection of the respiratory tract. It is transmitted by the inhalation of infected droplets and aerosols and by hand- to-mouth/eye contamination from an infected surface. The incubation period can be one to five days (average two to three days).
Groups affected by flu
Flu can affect anyone, but it is a more serious illness in babies, pregnant women, older people and those with certain underlying conditions.
Symptoms of flu
In healthy individuals, flu is usually an unpleasant but self-limiting illness with recovery in five to seven days. Common symptoms include the sudden onset of fever, chills, headache, myalgia (muscle aches) and severe fatigue. Sufferers can also experience a dry cough, sore throat and stuffy nose. In young children, gastrointestinal symptoms such as vomiting and diarrhoea may be seen.
Possible complications of flu
Common complications may include bronchitis, otitis media (middle ear infection) in children and sinusitis. Other less common complications include secondary bacterial pneumonia, viral pneumonia, meningitis and encephalitis.
In 2018/19 the one change in eligibility is the extension to an additional cohort of children, those in school year 5. Therefore, in 2018/19 the following are eligible for flu vaccination:
- all children aged two to nine (but not ten years or older) on 31 August 2018
- all primary school-aged children in former primary school pilot areas
- those aged six months to under 65 years in clinical risk groups
- pregnant women
- those aged 65 years and over
- those in long-stay residential care homes
We are offering the following specific vaccinations age related
- Quadrivalent vaccine is cost effective in those aged 6 months to 64 years in clinical risk groups.
- The adjuvanted trivalent vaccine is cost effective when administered to those aged 65 to 74 years.
- The adjuvanted trivalent vaccine is the only clinically effective and cost-effective option for those aged over 75 years.
Shingles vaccine should be offered to:
- patients aged 70 years, on or after their 70th birthday
- patients aged 78 years, on or after their 78th birthday
- patients who were eligible for immunisation in the previous programme years but have not yet been vaccinated against shingles. These are:
- anyone in their 70s who was born on or after 2/9/1942
- 79 year olds (until their 80th birthday).
Patients remain eligible until their 80th birthday. The programme does not offer patients the vaccine after they become 80 due to the reducing efficacy of the vaccine as age increases.
Pneumoccal PPV Vaccination eligibility
- Indicated for the active immunisation of individuals from 65 years.
- Single 0.5mL dose (except for those with asplenia, splenic dysfunction or chronic kidney disease who should be revaccinated every 5 years).
- Can be given anytime though out the year but be aware there is a national shortage of supply due to manufacturing issues and demand.
Please contact the surgery or book an appointment for your vaccination we are offering clinics at all sites during the week and designated weekends. Starting: from the 24th of September.